Insiders · IRD

Bernhard Hoffmann

SVP of Corp. Dev. at Opus Genetics, Inc. (IRD)

Bernhard Hoffmann has filed 6 insider reports with the SEC since February 2022, as SVP of Corp. Dev. at Opus Genetics, Inc. (IRD). The latest filing, on March 18, 2025, reports grant or award at Opus Genetics, Inc. (IRD).

Filings
6
Companies
1
Bought on market
None
Sold on market
None

Companies where Bernhard Hoffmann is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Opus Genetics, Inc. logo
IRD
Opus Genetics, Inc.
SVP of Corp. Dev.185,446$4.08Mar 18, 2025

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Bernhard Hoffmann with

Other insiders at the same companies

Questions about Bernhard Hoffmann

What is Bernhard Hoffmann's role at Opus Genetics, Inc.?
Bernhard Hoffmann reports to the SEC as SVP of Corp. Dev. at Opus Genetics, Inc. (IRD), according to the latest filing on March 18, 2025.
How many shares does Bernhard Hoffmann own?
After the latest filing that states it, Bernhard Hoffmann directly owned 185,446 shares of Opus Genetics, Inc. (IRD). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Bernhard Hoffmann bought or sold stock recently?
No open-market purchases or sales by Bernhard Hoffmann are on file. The filings report grant or award and shares withheld for taxes or exercise price.
How do I get alerts when Bernhard Hoffmann files?
Follow Bernhard Hoffmann on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Bernhard Hoffmann (SEC CIK 0001830354). Totals count each trade once, skipping amendments whose original is on file, from Feb 1, 2022 on. View on SEC EDGAR · Get this as JSON